glucosamine has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Hurlbert, MG; Jensen, SK; Keough, MB; Koch, M; Lau, LW; Ling, CC; Plemel, JR; Rawji, KS; Rogers, JA; Stephenson, EL; Yong, VW; Zhang, P | 1 |
| Gran, B; Rostami, A; Yu, S; Zhang, GX | 1 |
2 other study(ies) available for glucosamine and Multiple Sclerosis
| Article | Year |
|---|---|
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Topics: Animals; Animals, Newborn; Astrocytes; Carbohydrate Sequence; Cells, Cultured; Central Nervous System; Chondroitin Sulfate Proteoglycans; Female; Glucosamine; Humans; Mice, Inbred C57BL; Molecular Structure; Multiple Sclerosis; Oligodendroglia; Remyelination; Small Molecule Libraries; Stem Cells; Uridine Diphosphate Sugars | 2016 |
Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response.
Topics: Administration, Oral; Animals; Antigen-Presenting Cells; Cell Proliferation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Glucosamine; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Lymphocytes; Mice; Multiple Sclerosis; Myelin-Associated Glycoprotein; Nitric Oxide; Spinal Cord; Th2 Cells; Time Factors | 2005 |